seed
Stage
About
Clock develops a platform that uses genome-wide CRISPR screening and AI to discover and validate interventions that reverse cellular aging, initially focusing on skin rejuvenation topicals and nutraceuticals with plans to develop systemic therapies for extending healthspan.
Explore Clock's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.